| scholarly article | Q13442814 |
| P50 | author | Marian Groot Koerkamp | Q42356644 |
| P2093 | author name string | Lars von Oerthel | |
| Marten P. Smidt | |||
| Annemarie J. A. van der Linden | |||
| Frank C. P. Holstege | |||
| Jamie L. Lim | |||
| Jesse V. Veenvliet | |||
| Maria T. M. Alves Dos Santos | |||
| Marian J. A. Groot Koerkamp | |||
| Willemieke M. Kouwenhoven | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| Engrailed 1 | Q21498562 | ||
| Splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) | Q21989159 | ||
| Paired-like homeodomain transcription factor 3 | Q21989883 | ||
| P304 | page(s) | 3373–3384 | |
| P577 | publication date | 2013-08-01 | |
| P1433 | published in | Development | Q3025404 |
| P1476 | title | Specification of dopaminergic subsets involves interplay of En1 and Pitx3 | |
| P478 | volume | 140 |
| Q41730772 | A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease |
| Q48265173 | A novel floor plate boundary defined by adjacent En1 and Dbx1 microdomains distinguishes midbrain dopamine and hypothalamic neurons |
| Q39025701 | A review of the implication of hypoxanthine excess in the physiopathology of Lesch-Nyhan disease |
| Q64964421 | BMP/SMAD Pathway and the Development of Dopamine Substantia Nigra Neurons. |
| Q89893263 | Classification of Midbrain Dopamine Neurons Using Single-Cell Gene Expression Profiling Approaches |
| Q34609614 | Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling. |
| Q38752574 | Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons. |
| Q47760499 | Developmental Vitamin D (DVD) Deficiency Reduces Nurr1 and TH Expression in Post-mitotic Dopamine Neurons in Rat Mesencephalon |
| Q37190943 | Directed differentiation of postnatal hippocampal neural stem cells generates nuclear receptor related‑1 protein‑ and tyrosine hydroxylase‑expressing cells |
| Q38605280 | Dissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesis |
| Q93022796 | EN1 Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain Metastasis |
| Q61814302 | EZH2 Influences mdDA Neuronal Differentiation, Maintenance and Survival |
| Q64063277 | EZH2 Is Essential for Fate Determination in the Mammalian Isthmic Area |
| Q30835073 | Efficient generation of hPSC-derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform |
| Q33835242 | Embryonic development of selectively vulnerable neurons in Parkinson's disease. |
| Q39605796 | Engrailed 1 shapes the dopaminergic and serotonergic landscape through proper isthmic organizer maintenance and function |
| Q38598047 | Establishing diversity in the dopaminergic system |
| Q36248773 | Excessive Wnt/beta-catenin signaling promotes midbrain floor plate neurogenesis, but results in vacillating dopamine progenitors |
| Q38309820 | Genetic control of midbrain dopaminergic neuron development. |
| Q36109874 | Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson's Disease |
| Q92867094 | Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout |
| Q64093018 | Influences Correct Post-mitotic Coding of Mesodiencephalic Dopaminergic Neurons |
| Q37583989 | Mest/Peg1 Is Essential for the Development and Maintenance of a SNc Neuronal Subset |
| Q98178390 | Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells |
| Q41050801 | Molecular Programming of Mesodiencephalic Dopaminergic Neuronal Subsets. |
| Q38234170 | Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives. |
| Q48136803 | Mouse Fgf8-Cre-LacZ lineage analysis defines the territory of the postnatal mammalian isthmus. |
| Q38933629 | Neuronal survival in the brain: neuron type-specific mechanisms |
| Q26765693 | Neuroprotective Transcription Factors in Animal Models of Parkinson Disease |
| Q28550104 | Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic Neurons |
| Q41363585 | Pitx3 and En1 determine the size and molecular programming of the dopaminergic neuronal pool |
| Q36250893 | Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease |
| Q30833636 | Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease |
| Q36101048 | Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease |
| Q38894897 | Ruthenium complex Λ-WH0402 induces hepatocellular carcinoma LM6 (HCCLM6) cell death by triggering the Beclin-1-dependent autophagy pathway |
| Q102369133 | STRAP regulates alternative splicing fidelity during lineage commitment of mouse embryonic stem cells |
| Q59336248 | Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1 |
| Q46430873 | Tcf12 Is Involved in Early Cell-Fate Determination and Subset Specification of Midbrain Dopamine Neurons |
| Q47974836 | Transcription Factors: Potential Cell Death Markers in Parkinson's Disease |
| Q42378846 | Transcriptional repression of Plxnc1 by Lmx1a and Lmx1b directs topographic dopaminergic circuit formation. |
Search more.